We provide you with 20 years of free, institutional-grade data for CTMX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CTMX. Explore the full financial landscape of CTMX stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$4,953
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Ogden Christopher | Sale | -1,624 | $3.05 | $4,953 | 2026-06-17 |
| McCarthy Sean A. | Sale | -118,969 | $6.42 | $764,138 | 2026-03-19 |
| BELVIN MARCIA | Sale | -31,492 | $6.42 | $202,273 | 2026-03-19 |
| Ogden Christopher | Sale | -19,323 | $6.42 | $124,112 | 2026-03-19 |
| Chu Yu-Waye | Sale | -21,279 | $6.42 | $136,675 | 2026-03-19 |
| Lester Rachael | Grant, award...etc | 20,000 | 2026-02-04 | ||
| Chu Yu-Waye | Grant, award...etc | 75,000 | 2026-02-04 | ||
| BELVIN MARCIA | Grant, award...etc | 60,000 | 2026-02-04 | ||
| Ogden Christopher | Grant, award...etc | 90,000 | 2026-02-04 | ||
| McCarthy Sean A. | Grant, award...etc | 210,000 | 2026-02-04 | ||
| McCarthy Sean A. | Sale | -101,793 | $4.54 | $461,906 | 2025-11-10 |
| Ogden Christopher | Derivatives Exercise | 37,500 | 2025-06-17 | ||
| Ogden Christopher | Sale | -12,255 | $2.95 | $36,156 | 2025-06-17 |
| BELVIN MARCIA | Sale | -13,884 | $2.69 | $37,334 | 2025-06-17 |
| BELVIN MARCIA | Derivatives Exercise | 37,500 | 2025-06-17 | ||
| McCarthy Sean A. | Sale | -55,511 | $2.69 | $149,264 | 2025-06-17 |
| McCarthy Sean A. | Derivatives Exercise | 150,000 | 2025-06-17 | ||
| Ogden Christopher | Sale | -8,551 | $0.6 | $5,122 | 2025-03-20 |
| McCarthy Sean A. | Sale | -37,656 | $0.6 | $22,556 | 2025-03-20 |
| Chu Yu-Waye | Sale | -4,025 | $0.6 | $2,411 | 2025-03-20 |
| BELVIN MARCIA | Sale | -19,512 | $0.6 | $11,688 | 2025-03-20 |
| ROWLAND LLOYD A | Sale | -10,203 | $0.6 | $6,112 | 2025-03-20 |
| BELVIN MARCIA | Grant, award...etc | 92,500 | 2025-02-10 | ||
| BELVIN MARCIA | Grant, award...etc | 87,500 | 2025-02-06 | ||
| Chu Yu-Waye | Grant, award...etc | 113,500 | 2025-02-06 | ||
| Ogden Christopher | Grant, award...etc | 101,500 | 2025-02-06 | ||
| McCarthy Sean A. | Grant, award...etc | 375,000 | 2025-02-06 | ||
| Ogden Christopher | Sale | -1,984 | $1.23 | $2,439 | 2024-08-22 |
| Ogden Christopher | Derivatives Exercise | 6,875 | 2024-08-22 | ||
| McCarthy Sean A. | Sale | -13,898 | $1.23 | $17,082 | 2024-08-22 |
| McCarthy Sean A. | Derivatives Exercise | 37,500 | 2024-08-22 | ||
| Landau Jeffrey B | Sale | -4,181 | $1.23 | $5,139 | 2024-08-22 |
| Landau Jeffrey B | Derivatives Exercise | 11,250 | 2024-08-22 | ||
| BELVIN MARCIA | Sale | -4,181 | $1.23 | $5,139 | 2024-08-22 |
| BELVIN MARCIA | Derivatives Exercise | 11,250 | 2024-08-22 | ||
| ROWLAND LLOYD A | Sale | -4,181 | $1.23 | $5,139 | 2024-08-22 |
| ROWLAND LLOYD A | Derivatives Exercise | 11,250 | 2024-08-22 | ||
| Ogden Christopher | Grant, award...etc | 17,500 | 2024-06-14 | ||
| McCarthy Sean A. | Derivatives Exercise | 109,768 | 2024-03-28 | ||
| McCarthy Sean A. | Sale | -20,223 | $2.09 | $42,175 | 2024-03-21 |
| ROWLAND LLOYD A | Sale | -5,268 | $2.09 | $10,986 | 2024-03-21 |
| Ogden Christopher | Sale | -2,971 | $2.09 | $6,196 | 2024-03-21 |
| BELVIN MARCIA | Sale | -12,795 | $2.09 | $26,684 | 2024-03-21 |
| Landau Jeffrey B | Sale | -6,562 | $2.09 | $13,685 | 2024-03-21 |
| Ogden Christopher | Grant, award...etc | 40,000 | 2024-01-19 | ||
| BELVIN MARCIA | Grant, award...etc | 26,250 | 2024-01-19 | ||
| Landau Jeffrey B | Grant, award...etc | 30,000 | 2024-01-19 | ||
| Chu Yu-Waye | Grant, award...etc | 26,250 | 2024-01-19 | ||
| ROWLAND LLOYD A | Grant, award...etc | 25,000 | 2024-01-19 | ||
| McCarthy Sean A. | Grant, award...etc | 90,000 | 2024-01-19 | ||
| McCarthy Sean A. | Sale | -13,551 | $1.38 | $18,710 | 2023-12-22 |
| BELVIN MARCIA | Sale | -4,077 | $1.38 | $5,628 | 2023-12-22 |
| Landau Jeffrey B | Sale | -4,077 | $1.38 | $5,628 | 2023-12-22 |
| ROWLAND LLOYD A | Sale | -4,077 | $1.38 | $5,629 | 2023-12-22 |
| Ogden Christopher | Sale | -1,990 | $1.38 | $2,747 | 2023-12-22 |
| Landau Jeffrey B | Derivatives Exercise | 11,250 | 2023-12-19 | ||
| Ogden Christopher | Derivatives Exercise | 6,875 | 2023-12-19 | ||
| McCarthy Sean A. | Derivatives Exercise | 37,500 | 2023-12-19 | ||
| BELVIN MARCIA | Derivatives Exercise | 11,250 | 2023-12-19 | ||
| ROWLAND LLOYD A | Derivatives Exercise | 11,250 | 2023-12-19 | ||
| ROWLAND LLOYD A | Sale | -5,486 | $1.3 | $7,135 | 2023-09-22 |
| ROWLAND LLOYD A | Grant, award...etc | 15,000 | 2023-09-22 | ||
| McCarthy Sean A. | Sale | -14,601 | $1.3 | $18,987 | 2023-09-22 |
| McCarthy Sean A. | Grant, award...etc | 40,000 | 2023-09-22 | ||
| Landau Jeffrey B | Sale | -4,119 | $1.3 | $5,356 | 2023-09-22 |
| Landau Jeffrey B | Grant, award...etc | 11,250 | 2023-09-22 | ||
| BELVIN MARCIA | Sale | -4,119 | $1.3 | $5,356 | 2023-09-22 |
| BELVIN MARCIA | Grant, award...etc | 11,250 | 2023-09-22 | ||
| McCarthy Sean A. | Derivatives Exercise | 16,535 | 2023-05-23 | ||
| Jones Elaine V | Open Market Purchase | 5,000 | $1.55 | 2023-03-31 | |
| BELVIN MARCIA | Grant, award...etc | 60,000 | 2023-03-29 | ||
| BELVIN MARCIA | Initial | 2023-03-29 | |||
| Peterson Amy C. | Sale | -4,257 | $1.98 | $8,425 | 2023-03-20 |
| Ogden Christopher | Sale | -516 | $1.98 | $1,021 | 2023-03-20 |
| ROWLAND LLOYD A | Sale | -2,037 | $1.98 | $4,031 | 2023-03-20 |
| McCarthy Sean A. | Sale | -7,121 | $1.88 | $13,391 | 2023-03-20 |
| Campoy Carlos | Sale | -1,748 | $1.98 | $3,459 | 2023-03-20 |
| Landau Jeffrey B | Sale | -1,477 | $1.98 | $2,923 | 2023-03-20 |
The information provided in this report about CTMX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CytomX Therapeutics, Inc(NASDAQ:CTMX) 